Michael Metzger

Seasoned biopharmaceutical executive and CEO of Syndax Pharmaceuticals, with extensive experience in company building, M&A, and oncology drug development and commercialization.

Best podcasts with Michael Metzger

Ranked by the Snipd community

9 snips

Oct 8, 2025 • 27min

Syndax CEO Michael Metzger on Bold Leadership, Dual Drug Launches & Redefining Cancer Care

In this engaging discussion, Michael Metzger, CEO of Syndax Pharmaceuticals and a veteran in biopharmaceuticals, shares insights into their groundbreaking dual drug launches. He elaborates on the strategic in-licensing model that fueled their success and the meticulous due diligence behind choosing the right assets. Metzger also talks about the innovative menin inhibitor Revyforge and CSF1R antibody NICTIMVO, emphasizing their potential in oncology and the importance of pediatric care. His approach to tactical launch operations and data-driven strategies offers a fresh perspective on biotech growth.

The AI-powered Podcast Player

Save insights by tapping your headphones, chat with episodes, discover the best highlights - and more!

Get the app